Onderzoeker
Quentin Van Thillo
- Disciplines:Systeembiologie
Affiliaties
- Laboratorium voor Moleculaire Biologie van Leukemie (VIB-KU Leuven) (Afdeling)
Lid
Vanaf1 okt 2018 → Heden
Projecten
1 - 1 of 1
- Samenwerking van TLX3 met epigenetische veranderingen in de ontwikkeling van T-cel acute lymfatische leukemieVanaf1 okt 2018 → 20 okt 2022Financiering: FWO mandaten
Publicaties
1 - 8 van 8
- Revisiting a case of idiopathic hypereosinophilic syndrome with novel molecular techniques identifies a second case of a myeloid/lymphoid neoplasm with a SART3::PDGFRB fusion(2023)
Auteurs: Quentin Van Thillo, Barbara Dewaele, Jolien De Bie, Lucienne Michaux, Timothy Devos, Peter Vandenberghe
Pagina's: E7 - E10 - Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma(2022)
Auteurs: Marlies Vanden Bempt, Koen Debackere, Sofie Demeyer, Quentin Van Thillo, Nienke Meeuws, David Nittner, Thomas Tousseyn, Jan Cools, Daan Dierickx
Pagina's: 2463 - 2476 - Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study(2022)
Auteurs: Quentin Van Thillo, Iwein Gyselinck, Caroline Martens, Joost Wauters, Jan Gunst, Carine Wouters, Christophe Vandenbriele, Steffen Rex, Laurens Liesenborghs, Alexander Wilmer, et al.
- Oncogenic cooperation in T-cell acute lymphoblastic leukemia: the role of TLX3 and TCF7-SPI1(2022)
Auteurs: Quentin Van Thillo, Jan Cools, Charles De Bock
- Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma(2022)
Auteurs: Timothy Devos, Quentin Van Thillo, Iwein Gyselinck, Piet Maes, Laurens Liesenborghs, Ann Belmans, Peter Verhamme, Geert Meyfroidt
- Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia(2021)
Auteurs: Quentin Van Thillo, Jolien De Bie, Sofie Demeyer, Heidi Segers, Nancy Boeckx, Anne Uyttebroeck, Jan Cools
- A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study (vol 21, 1005, 2020)(2020)
Auteurs: Thomas Vanassche, MM Engelen, Quentin Van Thillo, Jan Gunst, Carine Wouters, Christophe Vandenbriele, Steffen Rex, L Liesenborghs, Alexander Wilmer, P Meersseman, et al.
- A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study(2020)
Auteurs: Thomas Vanassche, Quentin Van Thillo, Joost Wauters, Jan Gunst, Carine Wouters, Christophe Vandenbriele, Steffen Rex, Laurens Liesenborghs, Alexander Wilmer, Greet Van den Berghe, et al.